Spotlight Innovation Inc (STLT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Spotlight Innovation Inc (STLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8301
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized receptor binding proteins found in snake venom. It also develops therapeutics for the treatment of pain management derived from rattlesnake and cobra venom. Spotlight Innovation develops and commercializes drug candidates for the treatment of Zika Virus and spinal muscular atrophy. The company works in partnership with academic institutions and scientists. It operates through its subsidiaries to develop drugs. Spotlight Innovation is headquartered in Urbandale, Iowa, the US.

Spotlight Innovation Inc (STLT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spotlight Innovation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Spotlight Innovation Inc, Medical Devices Deals, 2012 to YTD 2018 10
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Spotlight Innovation Raises US$0.4 Million In Venture Financing 12
Partnerships 13
Spotlight Innovation Enters into Research Agreement with Indiana University 13
Spotlight Innovation Enters into Research Agreement with Brigham and Women’s Hospital 14
Spotlight Innovation Enters into Sponsored Research Agreement with Florida State University 15
Spotlight Innovation Enters into Research Agreement with University of Alabama at Birmingham 16
Spotlight Innovation Enters into Research Agreement with Emory University 17
Licensing Agreements 18
Spotlight Innovation Enters into Licensing Agreement with Florida State University 18
Spotlight Innovation Enters into Licensing Agreement with Florida State University Research Foundation 19
Spotlight Innovation Enters into Licensing Agreement with Indiana University Research & Technology 20
Caretta Therapeutics Enters into Licensing Agreement for Analgesic Products 21
Celtic Biotech Enters into Licensing Agreement with Instituto Butantan 22
Celtic Biotech Enters into Licensing Agreement for Chronic Kidney Disease 23
Equity Offering 24
Spotlight Innovation Raises USD0.5 Million in Private Placement of Shares and Warrants 24
Debt Offering 25
Spotlight Innovation Raises USD0.4 Million in Convertible Note Offering 25
Spotlight Innovation Raises USD0.8 Million in Private Placement of 6% Notes 26
Spotlight Innovation Raises USD1.4 Million in Private Placement 27
Acquisition 28
Spotlight Innovation Acquires Memcine Pharma 28
Spotlight Innovation Inc – Key Competitors 29
Spotlight Innovation Inc – Key Employees 30
Spotlight Innovation Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Corporate Communications 32
May 30, 2017: Spotlight Innovation Appoints Dr. June Beetler to Board of Directors 32
May 23, 2017: Spotlight Innovation Appoints John Krohn Interim Chief Executive Officer 33
Jan 10, 2017: Spotlight Innovation Appoints John Krohn President and Chief Operating Officer 34
Product News 35
Aug 07, 2017: New Chronic Pain Relief Product “Venodol” Now Available for Pre-order at Venodol.com 35
Jul 11, 2017: Spotlight Innovation Subsidiary Caretta Therapeutics Engages Public Relations Firm TransMedia Group 36
May 31, 2017: Spotlight Innovation Subsidiary Caretta Therapeutics Begins the Manufacturing Process for Venodol, a New Over-the-Counter Product to Treat Chronic Pain 37
Jan 18, 2017: Spotlight Innovation Subsidiary Caretta Therapeutics Announces Venodol, a New Over-the-counter Product to Treat Chronic Pain 38
Clinical Trials 39
Jul 24, 2018: Spotlight Innovation spinal muscular atrophy research collaborator professor Kevin Hodgetts receives $300,000 grant from Cure SMA 39
Feb 08, 2017: Spotlight Innovation Engages Top-Tier Contract Research Organization to Conduct Preclinical Studies of STL-182 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spotlight Innovation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spotlight Innovation Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Spotlight Innovation Inc, Medical Devices Deals, 2012 to YTD 2018 10
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Spotlight Innovation Raises US$0.4 Million In Venture Financing 12
Spotlight Innovation Enters into Research Agreement with Indiana University 13
Spotlight Innovation Enters into Research Agreement with Brigham and Women's Hospital 14
Spotlight Innovation Enters into Sponsored Research Agreement with Florida State University 15
Spotlight Innovation Enters into Research Agreement with University of Alabama at Birmingham 16
Spotlight Innovation Enters into Research Agreement with Emory University 17
Spotlight Innovation Enters into Licensing Agreement with Florida State University 18
Spotlight Innovation Enters into Licensing Agreement with Florida State University Research Foundation 19
Spotlight Innovation Enters into Licensing Agreement with Indiana University Research & Technology 20
Caretta Therapeutics Enters into Licensing Agreement for Analgesic Products 21
Celtic Biotech Enters into Licensing Agreement with Instituto Butantan 22
Celtic Biotech Enters into Licensing Agreement for Chronic Kidney Disease 23
Spotlight Innovation Raises USD0.5 Million in Private Placement of Shares and Warrants 24
Spotlight Innovation Raises USD0.4 Million in Convertible Note Offering 25
Spotlight Innovation Raises USD0.8 Million in Private Placement of 6% Notes 26
Spotlight Innovation Raises USD1.4 Million in Private Placement 27
Spotlight Innovation Acquires Memcine Pharma 28
Spotlight Innovation Inc, Key Competitors 29
Spotlight Innovation Inc, Key Employees 30
Spotlight Innovation Inc, Subsidiaries 31

List of Figures
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Spotlight Innovation Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Spotlight Innovation Inc (STLT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Samsung Heavy Industries Co Ltd:戦略・SWOT・企業財務分析
    Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Toyo Engineering Corp:企業の戦略・SWOT・財務分析
    Toyo Engineering Corp - Strategy, SWOT and Corporate Finance Report Summary Toyo Engineering Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MModal IP LLC:企業の戦略的SWOT分析
    MModal IP LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • PepVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PepVax Inc (PepVax) is a biotechnology company that develops novel therapeutics for the treatment of cancer. The company provides pipeline product candidate portfolio such as HCA587, which is being developing to treat hepatocellular carcinoma and TFDP3, a drug candidate which is being used f …
  • Sprint Corporation:企業の戦略・SWOT・財務分析
    Sprint Corporation - Strategy, SWOT and Corporate Finance Report Summary Sprint Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Chugoku Electric Power Co., Inc.:企業の戦略・SWOT・財務分析
    The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary The Chugoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • GOBARTO S.A.:戦略・SWOT・企業財務分析
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Falck Renewables S.p.A. (FKR):電力:M&Aディール及び事業提携情報
    Summary Falck Renewables S.p.A. (Falck Renewables), formerly Actelios S.p.A that develops, designs, constructs and manages energy production plants. It operates as a subsidiary of Falck S.p.A. The company produces clean energy from various renewable sources including wind energy, solar energy, bioma …
  • CCA Industries, Inc.:企業の戦略・SWOT・財務情報
    CCA Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary CCA Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Costcutter Supermarkets Group Limited:企業の戦略・SWOT・財務情報
    Costcutter Supermarkets Group Limited - Strategy, SWOT and Corporate Finance Report Summary Costcutter Supermarkets Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • BioVectra Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioVectra Inc (BioVectra), a subsidiary of Mallinckrodt Plc, is a contract development and manufacturing organization that offers cGMP outsourcing solutions for intermediates and active pharmaceutical ingredients. The organization's products include bioprocessing reagents, diagnostic reagent …
  • Firstec Co., Ltd.:企業の戦略・SWOT・財務分析
    Firstec Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Firstec Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Dentsu Inc (4324):企業の財務・戦略的SWOT分析
    Dentsu Inc (4324) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Stallergenes Greer plc (STAGR):企業の財務・戦略的SWOT分析
    Stallergenes Greer plc (STAGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Genting Bhd (GENTING):企業の財務・戦略的SWOT分析
    Genting Bhd (GENTING) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Liberty Holdings Ltd:戦略・SWOT・企業財務分析
    Liberty Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Liberty Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Beckman Research Institute Of The City Of Hope-製薬・医療分野:企業M&A・提携分析
    Summary Beckman Research Institute of The City Of Hope (Beckman Research), a subsidiary of City of Hope is a biomedical research institute that provides a range of healthcare services. The institute provides treatment that includes diabetes progression and treatment, immunology and imaging, mechanis …
  • PaR Systems LLC:企業の戦略的SWOT分析
    PaR Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Mesoblast Ltd (MSB):製薬・医療:M&Aディール及び事業提携情報
    Summary Mesoblast Ltd (Mesoblast) is a regenerative medicine company, which develops regenerative cell-based products. Its pipeline product candidates include MPC-150-IM, which is under development for the treatment of chronic congestive heart failure; MSC-100-IV, for the treatment of acute graft ve …
  • Noxilizer Inc-医療機器分野:企業M&A・提携分析
    Summary Noxilizer Inc (Noxilizer) is a medical device company that manufactures sterilization equipment. The company’s products include industrial nitrogen dioxide sterilizer and biodecontamination systems. Its services comprise installation, contract sterilization services, and maintenance services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆